Carolyn, I think you're absolutely right. This is a unique opportunity for Canada. The way I see it, the unique opportunity is coming from the fact, as Gail said, that they call them genetic diseases.
We are in the era of the personalized human genome project and personalized medicine. These diseases--and don't take this the wrong way--are the perfect templates to look for a solution for common diseases in the future at limited cost. So they could be wonderful approaches to unroll personalized medicine in Canada, since we know for most diseases the genetic origin and mechanism, and the industry can develop drugs for diagnosis and treatment for those orphan diseases.